Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
70
Expiration
May 21, 2027
DTE
226d
Moneyness
OTM
Intrinsic
$0.00
EWTX 70 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $0.05 | +400.00% | 1 | 251 |
| Nov 20, 2026 | 44d | $0.50 | -80.24% | 1 | 2 |
| Dec 18, 2026 | 72d | $0.85 | +0.00% | 1 | 1 |
| Jan 15, 2027 | 100d | $1.07 | -35.15% | 1 | 0 |
| Feb 19, 2027 | 135d | $1.05 | +0.00% | 1 | 1 |
| Mar 19, 2027 | 163d | $2.10 | +55.56% | 1 | 3 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.